Summary
The United States Food and Drug Administration gave it official permission.
This method is different because it removes the bad proteins instead of just blocking them.
It could change how doctors treat cancer in the future.
The medicine is called a PROteolysis Targeting Chimera, which tells cells to destroy bad proteins.
It received approval from the United States Food and Drug Administration.
It offers a new strategy for fighting cancers that were hard to treat before.
Scientists have been researching this technology for more than twenty years.
The approval means patients may soon have another treatment option.
The United States Food and Drug Administration gave it official permission.
This method is different because it removes the bad proteins instead of just blocking them.
It could change how doctors treat cancer in the future.
Want to learn even more? Click here to read the full story!